A PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.
Patients with prostate cancer are facing a unique situation amid the COVID-19 pandemic. Here are some of the resources the Prostate Cancer Foundation is offering to help patients in this turbulent situation.
A good nurse can make a huge difference for a patient struggling to deal with an illness, not only in comfort, or pain relief, or even in teaching how to manage symptoms or side effects – but in hope and confidence.